Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences

Emeryville, CA. — Sep. 02, 2009

Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at two healthcare conferences in September.
Robert W. Baird & Co. 2009 Health Care Conference
Onyx will present at the Robert W. Baird & Co. 2009 Health Care Conference in New York, New York, on September 9, 2021 at 9:30 a.m. Eastern Time.
Thomas Weisel Partners Healthcare Conference
Subsequently, Onyx will present at the Thomas Weisel Partners Healthcare Conference in Boston, Massachusetts, on September 10, 2021 at 12:55 p.m. Eastern Time.
Interested parties may access a live webcast of both presentations on our website at:
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentations will be available one hour following the conclusion of the presentations through October 9, 2009.
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar®, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company’s website at www.onyx pharm.com.
Nexavar® (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.
Return to 2009 Press Releases